-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Knowing which cells give rise to which parts of the cancer can improve our understanding of how a tumor grows and develops, including how it undergoes genetic changes over time
Current techniques for studying tumor cytogenetics involve taking samples from cancerous areas and analyzing the DNA of these cells
In a new study, funded by Cancer Research UK, published in the journal Nature, researchers used spatial transcriptomics to create cross-sectional maps of the entire prostate, including areas of healthy and cancerous cells
Alastair Lamb, of the Nuffield Department of Surgical Sciences at the University of Oxford, who co-led the research, said: "Prostate tissue is three-dimensional and, like most organs that are potentially carcinogenic, we still have a lot to learn about what cellular changes lead to Cancer, and where does it start
Professor Joakim Lundeberg, from KTH Royal Institute of Technology, said: "Mapping thousands of tissue regions in a single experiment is an unprecedented way to eliminate the heterogeneity of a tumor and its microenvironment
In addition, the researchers analyzed 150,000 regions in three prostates, two breast cancers, some skin, one lymph node, and some brain tissue, and developed an algorithm to track populations of cells with similar genetic changes at their precise locations
Protein, whole-transcriptome co-localization/co-detection and spatial morphological analysis on one slide! Get technical information and learn about the power of Visium Spatial Proteomics at 10x
Spatially resolved clonal copy number alterations in benign and malignant tissue